Mechanisms of Resistance to Androgen Deprivation Therapy in Advanced Castration-Resistant Prostate Cancer (CRPC)

Abstract

The overall hypothesis is that expression of the dipeptidase DPP4 is downregulated in prostate cancer (PCa) as a mechanism of resistance to androgen deprivation therapy (ADT). My overall objective is to demonstrate that DPP4 downregulation is a mechanism of ADT-resistance and PCa progression and to identify the specific pro-survival growth factor/cytokine targeted by DPP4 for degradation and its associated signaling cascade. Aim 1 will assess the effect ofDPP4 downregulation and overexpression on the sensitivity of PCa xenografts to castration. Aim 2 will identify the pro-survival growth factor/cytokine targeted by DPP4 for degradation and the downstream signaling cascades effected. Aim 3 will extend the significance of DPP4 downregulation into primary PCa and CRPC clinical specimens and assess the interaction ofDPP4 inhibition with ADT.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 01, 2022
Accession Number
AD1170062

Entities

People

  • Joshua W. Russo

Organizations

  • Beth Israel Deaconess Medical Center

Tags

DTIC Thesaurus Topics

  • Androgen Receptors
  • Androgens
  • Biomedical Research
  • Cell Line
  • Cells
  • Growth Factors
  • Health Services
  • Hormones
  • Immune System
  • Inhibition
  • Inhibitors
  • Lymphocytes
  • Materials
  • Medical Personnel
  • Neoplasms
  • Prostate
  • Prostate Cancer

Readers

  • Prostate Cancer Biology.